Children with a first-degree relative who has premature coronary artery disease or hypercholesterolemia should undergo fasting lipid screening between ages 2–10. Since the child is 10, screening is indicated.

Toronto Notes 2023 – Pediatrics, “Preventive Care in Children”:

“Lipid screening is recommended for children ≥2 years old with a family history of early cardiovascular disease or hypercholesterolemia.”

MCCQE1 Objectives (Pediatrics > 78-1: Preventive Medicine):

“Candidates must screen children at high risk of cardiovascular disease appropriately, including lipid profile for familial hyperlipidemia.”

Diet and exercise counseling may follow screening, but testing is the first step. Reassurance alone (C) is inappropriate. Homocysteine (E) and HbA1c are not first-line tests in this setting.

====================================================